Skip to content

Safety and Suitability of ICL for Correction of Refractive Errors Without the Use of Dispersive OVDs

Safety and Suitability of Implantable Collamer Lens (ICL) Implantation for Correction of Refractive Errors Without the Use of Dispersive Ophthalmic Viscosurgical Devices (OVDs)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06371079
Enrollment
448
Registered
2024-04-17
Start date
2024-03-01
Completion date
2024-08-22
Last updated
2024-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypermetropia, Myopia, Myopic Astigmatism, Refractive Errors

Keywords

refractive errors, myopia, hypermetropia, astigmatism, refractive surgery, ICL, ophthalmic viscosurgical device

Brief summary

The goal of this observational study is to test whether surgeries for lenses designed to be implanted in the eye to correct refractive error can be done without the need for using viscoelastic substances that are used routinely nowadays to make it easier to introduce them inside the human eye and protect the inside of the eye during the operation. The main question it aims to answer is that is it safe to do the surgery without using them? to answer this question researchers will access recorded data of patients that underwent refractive surgeries in a private clinic since 2017 and compare them as two groups: those who underwent the traditional procedures and those who had it without the use of dispersive viscoelastics in regard to their vision before and after surgery, their ocular pressure and biomicroscopic analysis of the inside of their corneas before and after surgery.

Detailed description

Records of patients that had undergone ICL implantation surgery in Al-Ferdows private eye hospital in Baghdad between 2017 and 2023 were accessed. Two groups of patients were identified, for the first group the ICL was implanted with the use of both dispersive and cohesive OVDs (traditional OVD group) and for the second one a novel method of implantation was used without utilizing dispersive OVD (reduced OVD) group. Both types of surgery were done by the same surgeon and in the same settings. The operative notes of the OVD group were as follows: under topical anesthesia if the ICL is toric, manual corneal marking is done in the sitting position using pendular marker. After loading of the ICL, two-step clear corneal main incision 2.8 mm in width with a bit long track of 1.5-2 mm to enhance its valve action was fashioned. Intracameral injection of dispersive OVD. The ICL was implanted with mouth-to-mouth technique. Anterior chamber reformation with cohesive OVD, then haptics are gently pushed behind the iris using an olive-tipped manipulator, ensuring alignment to proper axis in case of toric ICL, otherwise spherical ICL is placed directly at 180° axis. After that, AC (anterior chamber) wash with irrigation/aspiration is performed then stromal hydration was done to seal the surgical wound. In the reduced OVD group, modification to the traditional method involved omitting the step of dispersive OVD injection and instead utilizing Intracameral injection of 1:1 mixture of 1:1000 adrenaline and 2% lidocaine in an overfilling manner. All other surgical steps are performed in an identical manner. The study was ethically approved by the institutional review committee at the respective hospital and a similar committee at the college of medicine of university of Basrah according to the local guidelines and protocols. Written informed consent was obtained from each patient before the surgery. The study followed tenets of declaration of Helsinki. For both groups, records involving preoperative and postoperative assessments such as uncorrected and best corrected visual acuity, refractive error quantification both objectively utilizing an autorefractometer autorefractor Nidek ARK 1 (Nidek Inc, Gamagori, Japan) and subjectively as manifest refraction, clinical slit-lamp examination notes, intraocular pressure with non-contact air puff tonometer Topcon CT-1P (Topcon Inc., Tokyo, Japan), AC depth assessment by Pentacam Scheimpflug (Oculus Optikgeräte GmbH Inc., Wetzlar, Germany), specular microscopy study of corneal endothelial cells (endothelial cell density (ECD), coefficient of variation (CV) and hexagonality) using Topcon SP-1p Specular Microscope (Topcon Corporation, Tokyo, Japan), were accessed and analyzed using the latest software in SPSS. Patients with missing or incomplete data were excluded from the study. Exclusion criteria also included patients with severe ocular surface disease, unstable refraction, glaucoma, cataract, retinal detachment and uveitis. Unpaired t test or Mann-Whitney test was used to compare the two groups according to fulfilled statistical assumptions. Significance was considered at P value less than 0.05.

Interventions

DEVICEphakic intraocular lens implantation traditional

patients with refractive errors undergo surgical implantation of a lens inside the eye (implantable collamer lens or ICL) to correct these refractive errors. The procedure is done with help of use of both cohesive and dispersive OVD

DEVICEphakic intraocular lens implantation reduced OVD

patients with refractive errors undergo surgical implantation of a lens inside the eye (implantable collamer lens or ICL) to correct these refractive errors. The procedure is done with help of use of only cohesive OVD without using dispersive OVD.

Sponsors

Loay Abdulmutalib Almusawi
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Inclusion Criteria: * patients with refractive errors and stable refraction seeking refractive surgery who are fit for phakic IOL (intraocular lens) implantation and having reasonable improvement of visual acuity with refractive correction.

Exclusion criteria

* patients with severe ocular surface disease, unstable refraction, glaucoma, cataract, retinal detachment and uveitis.

Design outcomes

Primary

MeasureTime frameDescription
Unaided Visual Acuity After the Procedure1-2 years after the surgeryvisual acuity (vision of the patient) without use of any glasses measured using LogMar charts. This measure has no specified units

Secondary

MeasureTime frameDescription
Intraocular Pressure Postoperativelyfirst day, first week and first month after the procedureintraocular pressure in mmHg as measured by non-contact airpuff tonometer Topcon CT-1P (Topcon Inc., Tokyo, Japan). intraocular pressure is measured in millimeters of mercury
Specular Microscopy Parameter: Endothelial Cell Density1-2 years after the surgerydefined as the number of corneal endothelial cells per square millimeter of area, measured using the automated machine from Topcon SP-1P (Topcon Inc, Tokyo, Japan)
Specular Microscopy Parameter: Endothelial Cells Hexagonality1-2 years after the surgerydefined as the percentage of endothelial cells having 6 borders and shaped like a hexagon. this measure reflects the overall health of the endothelial cells and decreased hexagonality below 58-60% indicates corneal enodthelial pleomorphism, also measured using the automated machine from Topcon SP-1P (Topcon Inc, Tokyo, Japan)
Specular Microscopy Parameter: Coefficient of Variation of Corneal Endothelial Cells1-2 years after the surgeryThe standard deviation of the mean cell area divided by the mean cell area gives the coefficient of variation, a unitless number that is normally less than 0.30. it reflects the health of endothelial cells and measured using the automated machine from Topcon SP-1P (Topcon Inc, Tokyo, Japan).

Other

MeasureTime frameDescription
Postoperative Complicationsany time post op within the maximum 2 years follow up periodsuch as glaucoma, cataract, persistent uveitis, macular edema, endophthalmitis..etc.

Countries

Iraq

Participant flow

Recruitment details

Data from all patients that had undergone ICL implantation surgery for the correction of refractive errors in Al-Ferdows private eye hospital in Baghdad between 2017 and 2023 were accessed.

Pre-assignment details

The majority of the enrolled subjects were excluded from the study because most of their data were missing in the records. They cannot be analyzed as per study protocol

Participants by arm

ArmCount
Traditional OVD Group
In this group of patients, the ICL was implanted utilizing both cohesive and dispersive ophthalmic viscosurgical device. phakic intraocular lens implantation traditional: patients with refractive errors undergo surgical implantation of a lens inside the eye (implantable collamer lens or ICL) to correct these refractive errors. The procedure is done with help of use of both cohesive and dispersive OVD
46
Traditional OVD Group
In this group of patients, the ICL was implanted utilizing both cohesive and dispersive ophthalmic viscosurgical device. phakic intraocular lens implantation traditional: patients with refractive errors undergo surgical implantation of a lens inside the eye (implantable collamer lens or ICL) to correct these refractive errors. The procedure is done with help of use of both cohesive and dispersive OVD
78
Reduced OVD Group
In this group of patients, the ICL was implanted with the use of cohesive OVD only. phakic intraocular lens implantation reduced OVD: patients with refractive errors undergo surgical implantation of a lens inside the eye (implantable collamer lens or ICL) to correct these refractive errors. The procedure is done with help of use of only cohesive OVD without using dispersive OVD.
67
Reduced OVD Group
In this group of patients, the ICL was implanted with the use of cohesive OVD only. phakic intraocular lens implantation reduced OVD: patients with refractive errors undergo surgical implantation of a lens inside the eye (implantable collamer lens or ICL) to correct these refractive errors. The procedure is done with help of use of only cohesive OVD without using dispersive OVD.
121
Total312

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyMissing data88247

Baseline characteristics

CharacteristicTraditional OVD GroupTotalReduced OVD Group
Age, Continuous32.04 years
STANDARD_DEVIATION 7.39
30.23 years
STANDARD_DEVIATION 7.9
29.07 years
STANDARD_DEVIATION 8.04
Anterior Chamber Depth3.279 Millimeter
STANDARD_DEVIATION 0.299
3.297 Millimeter
STANDARD_DEVIATION 0.265
3.308 Millimeter
STANDARD_DEVIATION 0.241
Best-corrected Visual acuity.33 LogMAR
STANDARD_DEVIATION 0.12
.33 LogMAR
STANDARD_DEVIATION 0.11
.33 LogMAR
STANDARD_DEVIATION 0.11
Central corneal thickness493.0 micrometer
STANDARD_DEVIATION 38.83
492.3 micrometer
STANDARD_DEVIATION 42.86
491.8 micrometer
STANDARD_DEVIATION 45.6
Corneal endothelial cells hexagonality58.22 percentage
STANDARD_DEVIATION 10.55
58.27 percentage
STANDARD_DEVIATION 10.07
58.30 percentage
STANDARD_DEVIATION 9.77
Corneal endothelial coefficient of variation29.6 unitless
STANDARD_DEVIATION 4.4
29.6 unitless
STANDARD_DEVIATION 4.1
29.6 unitless
STANDARD_DEVIATION 3.9
Endothelial Cell Density2793.75 cells per square millimeter
STANDARD_DEVIATION 310.6
2861.47 cells per square millimeter
STANDARD_DEVIATION 312.6
2904.56 cells per square millimeter
STANDARD_DEVIATION 307.4
Intraocular pressure15.22 Millimeters of Mercury
STANDARD_DEVIATION 1.9
15.98 Millimeters of Mercury
STANDARD_DEVIATION 2.4
16.79 Millimeters of Mercury
STANDARD_DEVIATION 2.7
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
46 Participants113 Participants67 Participants
Region of Enrollment
Iraq
46 participants113 participants67 participants
Sex: Female, Male
Female
56 eyes135 eyes79 eyes
Sex: Female, Male
Male
22 eyes64 eyes42 eyes
Unaided visual acuity1.170 LogMAR
STANDARD_DEVIATION 0.196
1.175 LogMAR
STANDARD_DEVIATION 0.2
1.177 LogMAR
STANDARD_DEVIATION 0.21

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 460 / 67
other
Total, other adverse events
1 / 460 / 67
serious
Total, serious adverse events
0 / 460 / 67

Outcome results

Primary

Unaided Visual Acuity After the Procedure

visual acuity (vision of the patient) without use of any glasses measured using LogMar charts. This measure has no specified units

Time frame: 1-2 years after the surgery

Population: Those are participants with complete data and were considered for final statistical analysis

ArmMeasureValue (MEAN)Dispersion
Traditional OVD GroupUnaided Visual Acuity After the Procedure0.264 LogMar visionStandard Deviation 0.17
Reduced OVD GroupUnaided Visual Acuity After the Procedure0.227 LogMar visionStandard Deviation 0.12
Secondary

Intraocular Pressure Postoperatively

intraocular pressure in mmHg as measured by non-contact airpuff tonometer Topcon CT-1P (Topcon Inc., Tokyo, Japan). intraocular pressure is measured in millimeters of mercury

Time frame: first day, first week and first month after the procedure

ArmMeasureValue (MEAN)Dispersion
Traditional OVD GroupIntraocular Pressure Postoperatively17.44 mmHgStandard Deviation 4.46
Reduced OVD GroupIntraocular Pressure Postoperatively17.80 mmHgStandard Deviation 4.58
Secondary

Specular Microscopy Parameter: Coefficient of Variation of Corneal Endothelial Cells

The standard deviation of the mean cell area divided by the mean cell area gives the coefficient of variation, a unitless number that is normally less than 0.30. it reflects the health of endothelial cells and measured using the automated machine from Topcon SP-1P (Topcon Inc, Tokyo, Japan).

Time frame: 1-2 years after the surgery

ArmMeasureValue (MEAN)Dispersion
Traditional OVD GroupSpecular Microscopy Parameter: Coefficient of Variation of Corneal Endothelial Cells27.37 unitelessStandard Deviation 3.76
Reduced OVD GroupSpecular Microscopy Parameter: Coefficient of Variation of Corneal Endothelial Cells29.64 unitelessStandard Deviation 3.85
Secondary

Specular Microscopy Parameter: Endothelial Cell Density

defined as the number of corneal endothelial cells per square millimeter of area, measured using the automated machine from Topcon SP-1P (Topcon Inc, Tokyo, Japan)

Time frame: 1-2 years after the surgery

ArmMeasureValue (MEAN)Dispersion
Traditional OVD GroupSpecular Microscopy Parameter: Endothelial Cell Density2785.4 cells per square millimeterStandard Deviation 417.1
Reduced OVD GroupSpecular Microscopy Parameter: Endothelial Cell Density2851.0 cells per square millimeterStandard Deviation 305.1
Secondary

Specular Microscopy Parameter: Endothelial Cells Hexagonality

defined as the percentage of endothelial cells having 6 borders and shaped like a hexagon. this measure reflects the overall health of the endothelial cells and decreased hexagonality below 58-60% indicates corneal enodthelial pleomorphism, also measured using the automated machine from Topcon SP-1P (Topcon Inc, Tokyo, Japan)

Time frame: 1-2 years after the surgery

ArmMeasureValue (MEAN)Dispersion
Traditional OVD GroupSpecular Microscopy Parameter: Endothelial Cells Hexagonality58.69 percentage of hexagonal cellsStandard Deviation 10.43
Reduced OVD GroupSpecular Microscopy Parameter: Endothelial Cells Hexagonality57.93 percentage of hexagonal cellsStandard Deviation 9.26
Other Pre-specified

Postoperative Complications

such as glaucoma, cataract, persistent uveitis, macular edema, endophthalmitis..etc.

Time frame: any time post op within the maximum 2 years follow up period

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026